A former drug distributor filed a class action lawsuit against Novartis and Par Pharmaceuticals Friday, accusing the drugmakers of a pay-for-delay scheme to block generic competition for Novartis’ blood pressure drug Exforge (amlodipine and valsartan).
Source: Drug Industry Daily